Titelia

Funds holding Century Therapeutics Inc

ISIN US15673T1007 · United States

Fund holders
20
Of which ETFs
5 15 other funds
Value held
14.9M $
Share of capital
3.6 % of 181.1M shares on Aug 3, 2026
FundSharesValueWeight in fundShare of capital
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 4,339,8069.8M $0.00 %2.40 %as of Mar 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 1,205,2152.7M $0.00 %0.67 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 249,719579.3K $0.00 %0.14 %as of Feb 28, 2026
Dimensional U.S. Small Cap ETF Dimensional ETF Trust 121,810278.9K $0.00 %0.07 %as of Apr 30, 2026
Fidelity Total Market Index Fund Fidelity Concord Street Trust 94,676219.6K $0.00 %0.05 %as of Feb 28, 2026
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 94,419219.1K $0.00 %0.05 %as of Feb 28, 2026
Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST 79,415181.9K $0.00 %0.04 %as of Apr 30, 2026
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS 76,004171.8K $0.00 %0.04 %as of Mar 31, 2026
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 74,995174K $0.00 %0.04 %as of Feb 28, 2026
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS 65,179147.3K $0.00 %0.04 %as of Mar 31, 2026
Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust 62,076142.2K $0.00 %0.03 %as of Apr 30, 2026
U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 26,90561.6K $0.00 %0.01 %as of Apr 30, 2026
Avantis U.S. Small Cap Equity ETF American Century ETF Trust 19,86646.1K $0.00 %0.01 %as of Feb 28, 2026
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds 17,70040K $0.00 %0.01 %as of Mar 31, 2026
Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust 9,54321.9K $0.01 %as of Apr 30, 2026
Dimensional US Core Equity Market ETF Dimensional ETF Trust 9,37821.5K $0.00 %0.01 %as of Apr 30, 2026
U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 8,85420.3K $0.00 %0.00 %as of Apr 30, 2026
U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 7,44717.1K $0.00 %as of Apr 30, 2026
JNL/DFA U.S. Small Cap Fund JNL Series Trust 5,66212.8K $0.00 %0.00 %as of Mar 31, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 7251.7K $0.00 %0.00 %as of Apr 30, 2026

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust 0.00 %as of Apr 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 0.00 %as of Mar 31, 2026
Dimensional U.S. Small Cap ETF Dimensional ETF Trust 0.00 %as of Apr 30, 2026
Avantis U.S. Small Cap Equity ETF American Century ETF Trust 0.00 %as of Feb 28, 2026
JNL/DFA U.S. Small Cap Fund JNL Series Trust 0.00 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds 0.00 %as of Mar 31, 2026
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026
U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 0.00 %as of Apr 30, 2026

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q220+126,569,394+195.3 %
2026Q18-22,224,568-6.4 %
2025Q410-282,375,472-40.4 %
2025Q338-373,983,204-43.3 %
2025Q275-57,021,902-3.3 %
2025Q180-27,263,132-2.4 %
2024Q482-107,443,832+34.3 %
2024Q392+25,541,954+14.4 %
2024Q290+94,843,458-6.7 %
2024Q181-125,191,758-8.0 %
2023Q4935,642,766

Institutional managers

68 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
RA CAPITAL MANAGEMENT, L.P.17,754,43040.1M $as of Mar 31, 2026
TCG Crossover Management, LLC17,754,43039M $as of Mar 31, 2026
Versant Venture Management, LLC12,166,10927.5M $as of Mar 31, 2026
Deep Track Capital, LP9,487,74521.4M $as of Mar 31, 2026
Commodore Capital LP8,695,65219.7M $as of Mar 31, 2026
Venrock Adviser, LLC8,695,65219.7M $as of Mar 31, 2026
RTW INVESTMENTS, LP8,695,65219.7M $as of Mar 31, 2026
Point72 Asset Management, L.P.5,964,67813.5M $as of Mar 31, 2026
Balyasny Asset Management L.P.5,017,73311.3M $as of Mar 31, 2026
MILLENNIUM MANAGEMENT LLC4,667,06310.5M $as of Mar 31, 2026
Spruce Street Capital LP4,059,0549.2M $as of Mar 31, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.3,789,5388.6M $as of Mar 31, 2026
Woodline Partners LP3,043,4786.9M $as of Mar 31, 2026
Seven Fleet Capital Management LP2,947,8266.7M $as of Mar 31, 2026
Trails Edge Capital Partners, LP2,449,9935.5M $as of Mar 31, 2026
DAFNA Capital Management LLC2,434,3535.5M $as of Mar 31, 2026
TWO SIGMA INVESTMENTS, LP2,371,4305.4M $as of Mar 31, 2026
BlackRock, Inc.1,524,4223.4M $as of Mar 31, 2026
Rock Springs Capital Management LP1,304,3472.9M $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC1,301,6642.9M $as of Mar 31, 2026
Casdin Capital, LLC1,228,1902.8M $as of Mar 31, 2026
Syncona Portfolio Ltd1,213,0562.7M $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC906,8272M $as of Mar 31, 2026
MARSHALL WACE, LLP673,5841.5M $as of Mar 31, 2026
STATE STREET CORP386,723874K $as of Mar 31, 2026

Declared shareholders of Century Therapeutics Inc

There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
RTW Investments, LP and 1 other7.10 %13,043,478as of Mar 31, 2026 · SCHEDULE 13G
Point72 Asset Management, L.P. and 2 others3.30 %5,964,678as of Mar 31, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Funds holding Century Therapeutics Inc". https://titelia.com/en/stocks/century-therapeutics-inc-US15673T1007